These different isoform preferences of CDK5 between androgen-independent or dependent prostate cancer cell lines implies that CDK5 can modulate AR transcriptional activity through differential splicing in accordance with the present or absent of androgen. Here, CDK5 is linked to Familial prostate cancer.